chr6-108561360-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001455.4(FOXO3):c.152C>T(p.Thr51Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000262 in 1,563,620 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001455.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FOXO3 | NM_001455.4 | c.152C>T | p.Thr51Met | missense_variant | 1/3 | ENST00000406360.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FOXO3 | ENST00000406360.2 | c.152C>T | p.Thr51Met | missense_variant | 1/3 | 1 | NM_001455.4 | P1 | |
FOXO3 | ENST00000343882.10 | c.152C>T | p.Thr51Met | missense_variant | 2/4 | 1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000988 AC: 15AN: 151790Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.0000170 AC: 24AN: 1411718Hom.: 0 Cov.: 31 AF XY: 0.0000100 AC XY: 7AN XY: 698098
GnomAD4 genome AF: 0.000112 AC: 17AN: 151902Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74254
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 27, 2022 | The c.152C>T (p.T51M) alteration is located in exon 1 (coding exon 1) of the FOXO3 gene. This alteration results from a C to T substitution at nucleotide position 152, causing the threonine (T) at amino acid position 51 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at